Background. Prospective and case-control studies show that blood-pressure variability is an independent The 1-year mortality rate for patients on dialysis in risk factor for severe organ damage and cardiovascular Okinawa, Japan between 1971 and 1990 was 11.6%, events in hypertensives. We prospectively studied the which was higher than that for the general population association between systolic blood pressure variability (0.45%). Cardiovascular and cerebrovascular diseases and cardiovascular mortality and mortality from all accounted for 45.1% of dialysis patient deaths [1]. causes in end-stage renal disease patients.
Subjects and methods
blood pressure. The difference between the maximum and minimum systolic blood pressure (DSBP) in 1994 ranged from 44 to 146 mmHg (mean±SD, Subjects 78±13 mmHg) and correlated significantly with At the start of 1995, 144 patients who were undergoing coefficient of variation in systolic blood pressure (r= regular dialysis three times per week in a single dialysis unit 0.65, P<0.0001). Cox regression analysis was used to of Okinawa, Japan were selected. The subjects were 86 men identify the independent predictors for mortality. The (60%) and 58 women (40%) with a mean age of 52±13 years hazard ratio for death from all causes increased 1.63 (range 22-83) . This dialysis unit is one of those included in times per 1% increase in coefficient of variation in the Okinawa Dialysis Study (OKIDS) [1] . Some patients systolic blood pressure (hazard ratio; 95% confidence received dialysis in the morning and others received it in the interval: 1.63; 1.05-2.53) and 1.03 times per 1 mmHg evening; however, each patient always underwent dialysis in increase in DSBP (1.08; 1.03-1. 14) . Table 1 . Causes of death in 13 patients during the follow-up time of their administration varied from patient to patient period (1 January, 1995 to 28 February, 1998) and several types of drug were used over the study period in different patients; however, the patients were encouraged to take their medicine at a set recommended time every day. Smaller SBPCV Larger SBPCV range 7.8-10.1 range 10. 2-14.6 Patients in this cross-sectional study were evaluated from n=72 n=72
1 January 1995 to 28 February 1998 (38 months) . We reviewed all medical records and registered the cases in the OKIDS. Baseline demographic data other than blood pres-Cardiovascular sure were obtained in January 1994. were 144±15 mmHg and 77±7 mmHg respectively. Mean cholesterol concentration was 174±41 mg/dl.
Stroke events
Mean albumin and creatinine concentrations were 3.8±0.3 g/dl and 14.1±2.9 mg/dl respectively. The Newly developed cerebrovascular disease was diagnosed by coefficient of variation in systolic blood pressure, the both clinical symptoms and brain CT scan. Brain CT scan mean was 10.2±1.5%, median was 10.1%, and range was performed in all patients who were at risk for stroke. was 7.8-14.6%. The demographic data for patients in each half of the coefficient of variation in systolic Causes of death blood pressure range are shown in Table 2 . We subdivided the study population into two equal subgroups Cause of death was confirmed from medical records.
on either side of the median coefficient of variation in Classification of cause of death in dialysis patients was systolic blood pressure value. The demographic data defined previously [7] . In this paper, we modified this classification as shown in Table 1. of the two groups were compared univariately ( Table  2) and non-parametrically ( Figure 1 ). No significant differences in the prevalence of antihy-Statistical analysis pertensive medication and erythropoietin therapy were Descriptive statistics are reported as frequency and percent found between the groups ( Table 2 ). In addition, there for categorical data and as mean and SD or range for was no difference between the two groups with respect continuous data. Percentages were compared by x2 test. to the types of antihypertensive medication used Student's t-test was used to compare continuous variables. ( Table 3) .
Cumulative incidence curves were compared with the logrank test. Cox regression analysis was used to evaluate the Systolic blood pressure variability and clinical outcomes significance of risk factors for mortality due to cardiovascular events and to all causes. Significant risk factors for the model Three (2%) of the 144 patients underwent renal transwere chosen from a set of variables that included a coefficient plantation during the follow-up period. By Cox of variation in systolic blood pressure, gender, age, smoking, hazards model, the hazard ratio can be analysed even diabetes, duration of haemodialysis, antihypertensive medicawhen subjects are withdrawn for various reasons tion, systolic blood pressure, diastolic blood pressure, body weight gain between dialysis sessions, total cholesterol, serum during the course of the study [8] . Therefore, we included the patients' data when analysing the hazard pressure is a significant independent predictor for cardiovascular mortality (adjusted hazard ratio; 95% ratio. Of the 144 patients, 13 (9%) died during the follow-up period. Causes of mortality in these patients confidence interval: 1.78; 0.94-3.37), but revealed that it is an independent predictor for mortality from all are shown in Table 1 (6 cardiovascular and 7 noncardiovascular deaths occurred ). None of the patients causes (1.63; 1.05-2.53) ( Table 4) .
DSBP ranged from 44 to 146 mmHg (mean±SD, suffered from myocardial infarction during the followup period. Patients in the group with the greater 78±13 mmHg) and correlated significantly with coefficient of variation in systolic blood pressure (see coefficient of variation in systolic blood pressure were more likely to develop a cardiovascular fatal event (5 Figure 2) . One outlier in DSBP was identified statistically by Grubbs-Smirnov test. We excluded the patient's of 72, 7%) than patients in the first half of the range (1 of 72, 1%; P=0.211). Cox regression analysis failed data when analysing the hazard ratio of DSBP. Cox regression analysis failed to show that DSBP is a to show that coefficient of variation in systolic blood aAdjustments were made for age, gender, duration of dialysis, diabetes, smoking habit, antihypertensive medication, systolic blood pressure, diastolic blood pressure, body weight gain between dialysis sessions, total cholesterol, serum albumin, and serum creatinine. CI, confidence interval; SBPCV, coefficient of variation in systolic blood pressure, DSBP, the difference between the maximum and minimum systolic blood pressure in 1994.
diabetes, smoking, blood pressure, and cholesterol, which were risk factors for cardiovascular disease, and albumin, which has been shown to be a risk factor for death in patients with ESRD [9-12]. Other clinical factors such as duration of haemodialysis and antihypertensive medication used were also not significant. The cumulative incidence of cardiovascular death in the patients with the higher range of coefficient of variation in systolic blood pressure was greater than that for patients with the lower range, but the difference was not significant (P=0.092, see Figure 1 , left panel ). The cumulative incidence of death from all causes for patients in the larger coefficient of variation in systolic blood pressure group was significantly higher than that for patients in the smaller coefficient of variation in systolic blood pressure group (P=0.039, see Figure 1 , right panel ). This study extends previous analyses in case-control studies of hypertensives [2,3] and pregnant women [4] significant independent predictor for cardiovascular mortality (adjusted hazard ratio; 95% confidence inter-and shows prospectively that there is a relation between systolic blood pressure variability and mortality in val: 1.75; 0.82-3.73), but revealed that it is an independent predictor for mortality from all causes (1.08; patients with ESRD.
A large number of papers [13] [14] [15] [16] [17] [18] have described 1.03-1.14) ( Table 4) .
These results correspond to the hazard ratio for seasonal variation of blood pressure. Therefore we calculated the coefficient of variation in SBP from the death from all causes, which increased 1.63 per 1% increase in coefficient of variation in systolic blood complete year records of SBP in this study. We analysed coefficient of variation in systolic blood pressure pressure and 1.08 per 1 mmHg increase in DSBP.
No significant results were obtained for age, gender, but not coefficient of variation in diastolic blood pressure because SBP correlates better than DBP does system may also be a possible factor in this situation because sympathetic overactivity is a common finding with epidemiological end-points [19, 20] .
The incidence of acute myocardial infarction in in end-stage renal disease and it correlates with the increase in both vascular resistance and systemic blood dialysis patients in Okinawa, Japan was 1.1 per 1000 cases/year between April 1988 and March 1991 [21]; pressure [29] . Afferent signals from the kidney may be the mechanism for this overactivity [29] . However, all in other words, the rate was only 0.5 per 141 persons over 3 years. No myocardial infarction occurred in our 144 patients in this study had end-stage renal disease.
If a disorder of the autonomic nervous system was study patients during the follow-up period, which was compatible with the statistics in Okinawa, Japan.
involved, the degree of disorder suffered by the patients should be different between the two coefficient of Our method of BP sampling was different from those used in previous studies. Frattola et al. [2] and Ayala variation in systolic blood pressure groups, and this was not the case. Finally, sodium sensitivity also may et al. [4] took hour-to-hour circadian blood pressure, Hata et al. [3] used month-to-month measurements be a mechanism that contributes to this relation because sodium sensitivity is an independent risk factor for a year, and we took three measurements per week for a year. Although the BP sampling methods differed, for cardiovascular events in essential hypertension [30] and the daily variability of sodium intake may influence all these reports showed a positive association between BP variability and adverse events.
the variability of blood pressure.
Limitations of the present study include the relatively Determination of coefficient of variation in systolic blood pressure calculated from complete records of a short duration of follow-up (38 months), the small patient numbers and the late stage in the entire course full year of sessions may not be realistic for general use. Therefore, we introduced DSBP as an index of the of dialysis treatment (average 80 months). An analysis of subsets such as elderly patients or patients in the variability of SBP and as an alternative to coefficient of variation in systolic blood pressure. Although the early stages of dialysis could not be performed. All the patients survived while on haemodialysis through all adjusted hazard ratio of DSBP is lower than that of coefficient of variation in systolic blood pressure for of 1994 and, therefore, these patients may have a better prognosis than other ESRD patients. mortality from all causes, the hazard ratio is significant ( Table 4 ). This suggests that DSBP is a feasible,
In summary, the present study suggests that patients with increased systolic blood pressure variability are acceptable variable for predicting prognosis in endstage renal disease. more likely to develop fatal events. Further study is needed to establish methods of risk reduction. Relative hypotension [22] and low diastolic blood pressure [23] are risk factors for mortality in dialysis Acknowledgements. We acknowledge the secretarial assistance of Ms patients. In our univariate and non-parametric ana-Chiho Iseki and the cooperation of other secretarial and nursing lyses, patients whose coefficient of variation in systolic staff in Okinawa Dai-ich Hospital. blood pressure was in the range above the median had lower DBP and a worse prognosis than those in the range below the median. Cox regression analysis with References an adjustment for multiple factors, however, showed that DBP was not a significant risk factor. In previous 1. Iseki different between the two groups.
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